Skip to main content
Glama

Pharma Intel

by io.github.pipeworx-io

AI Visibility Check

ai_visibility_check
Read-onlyIdempotent

Probe one or more LLMs for what they know about a business / brand / product / topic and score visibility (0-100) per model. Default model is Workers AI Llama-3.3-70b (free); pass _apiKey to also probe Anthropic (BYO key — you pay Anthropic directly for those calls). Returns per-model {score, confidence, signals, raw_response} + a combined view. Useful for AI-marketing audits, pre-launch brand checks, competitive monitoring.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
entityYesThe thing to ask about. Brand/business name, product name, person, or topic. E.g. "Pipeworx", "OpenInvoice", "Acme Corp pricing".
modelsNoWhich models to probe. Supported: "workers-ai" (free default), "anthropic" (requires _apiKey). Omit for just workers-ai.
_apiKeyNoOptional Anthropic API key (sk-ant-...) — only needed if "anthropic" is in models. Passed straight through to api.anthropic.com.
contextNoOptional: a phrase locating the entity (e.g. "Boston restaurant", "B2B SaaS"). Helps disambiguate common names.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.5/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readonly/open/idempotent. Description adds return format (per-model objects + combined view) and cost implication for Anthropic calls. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Three sentences, front-loaded with main purpose. Every sentence adds necessary information, no fluff.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Covers purpose, parameters, behavior, return format, and use cases. Adequate despite missing output schema; return format is described.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but description adds value: default model behavior, API key dependency, context disambiguation. Enhances understanding beyond schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Clearly states the action (probe/score) and resource (LLMs for a given entity). Distinguishes from sibling tools, none of which duplicate this functionality.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explains default model and optional Anthropic integration with BYO key. Provides use cases (AI-marketing audits, brand checks). Lacks explicit 'when not to use' but sufficient.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Pharma Intel toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.1/5.0
Disambiguation5/5

Every tool has a clearly distinct purpose, even within the same domain (e.g., ask_pipeworx vs ask_pipeworx_grounded vs ask_pipeworx_beta are differentiated by groundedness/beta status; polymarket_edges vs polymarket_arbitrage vs polymarket_fill_risk each target discovery vs arbitrage vs execution risk). The descriptions are highly detailed, eliminating ambiguity about when to use each.

Naming Consistency4/5

All tool names use snake_case consistently, and most follow a verb-first pattern (ask_, compare_, discover_, search_, validate_), but a few are noun-first (entity_profile, polymarket_edges, recent_alerts). The style is readable and predictable, though not perfectly uniform in the verb_noun convention.

Tool Count2/5

With 37 tools, the server is heavily over-scoped, especially given the 'Pharma Intel' name that suggests a focused pharma domain. Many tools are general-purpose (prediction markets, memory, subscription management, feedback) unrelated to the server's apparent purpose, making it feel like a grab bag rather than a cohesive set.

Completeness4/5

The pharma-specific tools cover drug profiles, safety, pipeline scans, catalysts, indication landscapes, and sponsor diligence – a solid lifecycle coverage. The broader data/query/prediction-market tools also feel complete for their respective sub-domains. The only minor gaps are niche operations (e.g., updating a subscription), but these are not critical to the core workflows.

Resources